Skip to main content
Log in

Polycystic ovary syndrome

  • Review
  • Published:
Frontiers of Medicine in China Aims and scope Submit manuscript

An Erratum to this article was published on 30 December 2010

Abstract

Polycystic ovary syndrome (PCOS) is a common gynecologic endocrinopathy. The pathogenesis of PCOS is associated with both heredity and environment. PCOS has adverse impacts on female endocrine, reproduction, and metabolism. PCOS can impact women’s reproductive health, leading to anovulatory infertility and higher rate of early pregnancy loss. PCOS has additional metabolic derangements, such as insulin resistance, impaired glucose tolerance, and dyslipidemia. The risks of diabetes, cardiovascular disease, hypertension, metabolic syndrome, and endometrial cancer among PCOS patients are significantly increased as well.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Azziz R, Woods K S, Reyna R, Key T J, Knochenhauer E S, Yildiz B O. The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab, 2004, 89(6): 2745–2749

    Article  CAS  PubMed  Google Scholar 

  2. Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod, 2004, 19(1): 41–47

    Article  Google Scholar 

  3. Chen Z J, Shi Y H, Zhao Y R, Li Y, Tang R, Zhao L X, Chang Z H. Correlation between single nucleotide polymorphism of insulin receptor gene with polycystic ovary syndrome. Zhonghua Fu Chan Ke Za Zhi, 2004, 39(9): 582–585 (in Chinese)

    PubMed  Google Scholar 

  4. Wang K, You L, Shi Y, Wang L, Zhang M, Chen Z J. Association of genetic variants of insulin degrading enzyme with metabolic features in women with polycystic ovary syndrome. Fertil Steril, 2008, 90(2): 378–384

    Article  CAS  PubMed  Google Scholar 

  5. Zhang N, Shi Y H, Hao C F, Gu H F, Li Y, Zhao Y R, Wang L C, Chen Z J. Association of +45G15G(T/G) and +276(G/T) polymorphisms in the ADIPOQ gene with polycystic ovary syndrome among Han Chinese women. Eur J Endocrinol, 2008, 158(2): 255–260

    Article  CAS  PubMed  Google Scholar 

  6. Diao X H, Shi Y H, Gao Q, Wang L C, Tang R, Chen Z J. Relationship between single nucleotide polymorphism-56 of calpain-10 gene and glucose and lipid metabolism in polycystic ovary syndrome patients. Zhonghua Fu Chan Ke Za Zhi, 2008, 43(2): 106–109 (in Chinese)

    CAS  PubMed  Google Scholar 

  7. Lee J Y, Lee W J, Hur S E, Lee C M, Sung Y A, Chung H W. 111/121 diplotype of Calpain-10 is associated with the risk of polycystic ovary syndrome in Korean women. Fertil Steril, 2009, 92(2): 830–833

    Article  PubMed  Google Scholar 

  8. Hao C F, Bao H C, Zhang N, Gu H F, Chen Z J. Evaluation of association between the CYP11alpha promoter pentannucleotide (TTTTA)n polymorphism and polycystic ovarian syndrome among Han Chinese women. Neuro Endocrinol Lett, 2009, 30(1): 56–60

    CAS  PubMed  Google Scholar 

  9. Van Nieuwerburgh F, Stoop D, Cabri P, Dhont M, Deforce D, De Sutter P. Shorter CAG repeats in the androgen receptor gene may enhance hyperandrogenicity in polycystic ovary syndrome. 2008, 24(12): 669–673

    Google Scholar 

  10. Ferk P, Perme M P, Teran N, Gersak K. Androgen receptor gene (CAG)n polymorphism in patients with polycystic ovary syndrome, 2008, 90(3): 860–863

    CAS  Google Scholar 

  11. Christopoulos P, Mastorakos G, Gazouli M, Deligeoroglou E, Katsikis I, Diamanti-Kandarakis E, Panidis D, Creatsas G. Study of association of IRS-1 and IRS-2 genes polymorphisms with clinical and metabolic features in women with polycystic ovary syndrome. Is there an impact? Gynecol Endocrinol, 2010 March 9 [Epub ahead of print]

  12. Fan P, Liu H W, Wang X S, Zhang F, Song Q, Li Q, Wu H M, Bai H. Identification of the G994T polymorphism in exon 9 of plasma platelet-activating factor acetylhydrolase gene as a risk factor for polycystic ovary syndrome. Hum Reprod, 2010, 25(5): 1288–1294

    Article  CAS  PubMed  Google Scholar 

  13. Sproul K, Jones M R, Mathur R, Azziz R, Goodarzi M O. Association study of four key folliculogenesis genes in polycystic ovary syndrome. BJOG, 2010, 117(6): 756–760

    Article  CAS  PubMed  Google Scholar 

  14. Vural P, Değirmencioğlu S, Saral N Y, Akgül C. Tumor necrosis factor alpha (−308), interleukin-6 (−174) and interleukin-10 (−1082) gene polymorphisms in polycystic ovary syndrome. Eur J Obstet Gynecol Reprod Biol, 2010, 150(1): 61–65

    Article  CAS  PubMed  Google Scholar 

  15. Wang K, Wang L, Zhao Y, Shi Y, Wang L, Chen Z J. No association of the Arg51Gln and Leu72Met polymorphisms of the ghrelin gene and polycystic ovary syndrome. Hum Reprod, 2009, 24(2): 485–490

    Article  CAS  PubMed  Google Scholar 

  16. Zheng Q, Shi Y, Yang Z, Xu X, Wang L, Xue F, Gu H F, Chen Z J. Family-based association study of the MCF 2L2 gene and polycystic ovary syndrome. Gynecol Obstet Invest, 2009, 68(3): 171–173

    Article  CAS  PubMed  Google Scholar 

  17. Ewens K G, Stewart D R, Ankener W, Urbanek M, McAllister J M, Chen C, Baig K M, Parker S C, Margulies E H, Legro R S, Dunaif A, Strauss J F 3rd, Spielman R S. Family-based analysis of candidate genes for polycystic ovary syndrome. J Clin Endocrinol Metab, 2010, 95(5): 2306–2315

    Article  CAS  PubMed  Google Scholar 

  18. Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale H F, Futterweit W, Janssen O E, Legro R S, Norman R J, Taylor A E, Witchel S F. The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. Fertil Steril, 2009, 91(2): 456–488

    Article  PubMed  Google Scholar 

  19. Homburg R. Androgen circle of polycystic ovary syndrome. Hum Reprod, 2009, 24(7): 1548–1555

    Article  CAS  PubMed  Google Scholar 

  20. Blank S K, McCartney C R, Helm K D, Marshall J C. Neuroendocrine effects of androgens in adult polycystic ovary syndrome and female puberty. Semin Reprod Med, 2007, 25(5): 352–359

    Article  CAS  PubMed  Google Scholar 

  21. Homburg R. Pregnancy complications in PCOS. Best Pract Res Clin Endocrinol Metab, 2006, 20(2): 281–292

    Article  PubMed  Google Scholar 

  22. Heijnen E M, Eijkemans M J, Hughes E G, Laven J S, Macklon N S, Fauser B C. A meta-analysis of outcomes of conventional IVF in women with polycystic ovary syndrome. Hum Reprod Update, 2006, 12(1): 13–21

    Article  CAS  PubMed  Google Scholar 

  23. Boomsma C M, Eijkemans M J C, Hughes E G, Visser G H, Fauser B C, Macklon N S. A meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome. Hum Reprod Update, 2006, 12(6): 673–683

    Article  CAS  PubMed  Google Scholar 

  24. Vrbikova J, Hainer V. Obesity and polycystic ovary syndrome. Obes Facts, 2009, 2(1): 26–35

    Article  PubMed  Google Scholar 

  25. Cupisti S, Kajaia N, Dittrich R, Duezenli H, W Beckmann M, Mueller A. Body mass index and ovarian function are associated with endocrine and metabolic abnormalities in women with hyperandrogenic syndrome. Eur J Endocrinol, 2008, 158(5): 711–719

    Article  CAS  PubMed  Google Scholar 

  26. Wagenknecht L E, Langefeld C D, Scherzinger A L, Norris J M, Haffner S M, Saad M F, Bergman R N. Insulin sensitivity, insulin secretion, and abdominal fat: the Insulin Resistance Atherosclerosis Study (IRAS) Family Study. Diabetes, 2003, 52(10): 2490–2496

    Article  CAS  PubMed  Google Scholar 

  27. Glueck C J, Papanna R, Wang P, Goldenberg N, Sieve-Smith L. Incidence and treatment of metabolic syndrome in newly referred women with confirmed polycystic ovarian syndrome. Metabolism, 2003, 52(7): 908–915

    Article  CAS  PubMed  Google Scholar 

  28. Palomba S, Falbo A, Russo T, Orio F, Tolino A, Zullo F. Systemic and local effects of metformin administration in patients with polycystic ovary syndrome (PCOS): relationship to the ovulatory response. Hum Reprod, 2010, 25(4): 1005–1013

    Article  CAS  PubMed  Google Scholar 

  29. Toprak S, Yönem A, Cakir B, Güler S, Azal O, Ozata M, Corakçi A. Insulin resistance in nonobese patients with polycystic ovary syndrome. Horm Res, 2001, 55(2): 65–70

    Article  CAS  PubMed  Google Scholar 

  30. Dunaif A, Segal K R, Futterweit W, Dobrjansky A. Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes, 1989, 38(9): 1165–1174

    Article  CAS  PubMed  Google Scholar 

  31. Apridonidze T, Essah P A, Iuorno M J, Nestler J E. Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome. J Clin Endocrinol Metab, 2005, 90(4): 1929–1935

    Article  CAS  PubMed  Google Scholar 

  32. Dokras A. Cardiovascular disease risk factors in polycystic ovary syndrome. Semin Reprod Med, 2008, 26(1): 39–44

    Article  CAS  PubMed  Google Scholar 

  33. Rocha M P, Maranhão R C, Seydell T M, Barcellos C R, Baracat E C, Hayashida S A, Bydlowski S P, Marcondes J A. Metabolism of triglyceride-rich lipoproteins and lipid transfer to high-density lipoprotein in young obese and normal-weight patients with polycystic ovary syndrome. Fertil Steril, 2010, 93(6): 1948–1956

    Article  CAS  PubMed  Google Scholar 

  34. Soares E M, Azevedo G D, Gadelha R G, Lemos T M, Maranhão T M. Prevalence of the metabolic syndrome and its components in Brazilian women with polycystic ovary syndrome. Fertil Steril, 2008, 89(3): 649–655

    Article  PubMed  Google Scholar 

  35. Lo J C, Feigenbaum S L, Yang J, Pressman A R, Selby J V, Go A S. Epidemiology and adverse cardiovascular risk profile of diagnosed polycystic ovary syndrome. J Clin Endocrinol Metab, 2006, 91(4): 1357–1363

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Zi-Jiang Chen.

Additional information

An erratum to this article can be found at http://dx.doi.org/10.1007/s11684-010-0330-0

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chen, ZJ., Shi, Y. Polycystic ovary syndrome. Front. Med. China 4, 280–284 (2010). https://doi.org/10.1007/s11684-010-0098-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11684-010-0098-2

Keywords

Navigation